Levodopa is not a useful treatment for Lesch-Nyhan disease

Movement Disorders

Volumn 26, Issue 4, 2011, Pages 746-749

  Visser, Jasper E ^a,b   Schretlen, David J ^c   Bloem, Bastiaan R ^a   Jinnah, Hyder A ^d  

^a RADBOUD UNIVERSITY   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dyskinesias; Dystonia; Lesch Nyhan disease; Levodopa; Self injurious behavior; Treatment

Indexed keywords

CARBIDOPA PLUS LEVODOPA;

ADULT; ARTICLE; AUTOMUTILATION; BEHAVIOR; CHILD; CHOREA; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSTONIA; HEMIBALLISM; HUMAN; HYPERACTIVITY; HYPERREFLEXIA; LESCH NYHAN SYNDROME; LIMB DISEASE; LOW DRUG DOSE; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; MUSCLE RIGIDITY; MUSCLE STIFFNESS; OPEN STUDY; OPISTHOTONUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TIC; TONGUE DISEASE; TREATMENT DURATION;

ADULT; ANTIPARKINSON AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LESCH-NYHAN SYNDROME; LEVODOPA; MALE; TREATMENT OUTCOME;

EID: 79955003719     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23478     Document Type: Article

References (30)

1. Lesch M, Nyhan WL. A familial disorder or uric acid metabolism and central nervous system function. Am J Med 1964; 36: 561-570.
2. Jinnah HA, Friedmann T. Lesch-Nyhan disease and its variants. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001. p 2537-2570.
3. Jinnah HA, Visser JE, Harris JC, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 2006; 129: 1201-1217.
4. Schretlen DJ, Harris JC, Park KS, Jinnah HA, del Pozo NO. Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency. J Int Neuropsychol Soc 2001; 7: 805-812.
5. Matthews WS, Solan A, Barabas G. Cognitive functioning in Lesch-Nyhan syndrome. Dev Med Child Neurol 1995; 37: 715-722.
6. Lloyd KG, Hornykiewicz O, Davidson L, et al. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med 1981; 305: 1106-1111.
7. Saito Y, Ito M, Hanaoka S, Ohama E, Akaboshi S, Takashima S. Dopamine receptor upregulation in Lesch-Nyhan syndrome: a postmortem study. Neuropediatrics 1999; 30: 66-71.
8. Wong DF, Harris JC, Naidu S, et al. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci USA 1996; 93: 5539-5543.
9. Ernst M, Zametkin AJ, Matochik JA, et al. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 1996; 334: 1568-1572.
10. Dunnett SB, Sirinathsinghji DJ, Heavens R, Rogers DC, Kuehn MR. Monoamine deficiency in a transgenic (Hprt-) mouse model of Lesch-Nyhan syndrome. Brain Res 1989; 501: 401-406.
11. Finger S, Heavens RP, Sirinathsinghji DJ, Kuehn MR, Dunnett SB. Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome. J Neurol Sci 1988; 86: 203-213.
12. Jinnah HA, Wojcik BE, Hunt M, et al. Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci 1994; 14: 1164-1175.
13. Egami K, Yitta S, Kasim S, et al. Basal ganglia dopamine loss due to defect in purine recycling. Neurobiol Dis 2007; 26: 396-407.
14. Manzke H, Gustmann H, Koke HG, Nyhan WL. Hypoxanthine and tetrahydrobiopterin treatment of a patient with features of the Lesch-Nyhan syndrome. Adv Exp Med Biol 1986; 195(Pt A): 197-203.
15. Serrano M, Perez-Duenas B, Ormazabal A, et al. Levodopa therapy in a Lesch-Nyhan disease patient: pathological, biochemical, neuroimaging, and therapeutic remarks. Mov Disord 2008; 23: 1297-1300.
16. Mizuno TI, Yugari Y. Letter: self mutilation in Lesch-Nyhan syndrome. Lancet 1974; 1: 761.
17. Jankovic J, Caskey TC, Stout JT, Butler IJ. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Ann Neurol 1988; 23: 466-469.
18. Watts RW, Spellacy E, Gibbs DA, Allsop J, McKeran RO, Slavin GE. Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the Neurological manifestations. Q J Med 1982; 51: 43-78.
19. Hunter TC, Melancon SB, Dallaire L, et al. Germinal HPRT splice donor site mutation results in multiple RNA splicing products in T-lymphocyte cultures. Somat Cell Mol Genet 1996; 22: 145-150.
20. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985; 35: 73-77.
21. Visser JE, Bar PR, Jinnah HA. Lesch-Nyhan disease and the basal ganglia. Brain Res Brain Res Rev 2000; 32: 449-475.
22. Muller U. The monogenic primary dystonias. Brain 2009; 132: 2005-2025.
23. Moy SS, Criswell HE, Breese GR. Differential effects of bilateral dopamine depletion in neonatal and adult rats. Neurosci Biobehav Rev 1997; 21: 425-435.
24. Breese GR, Baumeister AA, McCown TJ, et al. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharmacol Exp Ther 1984; 231: 343-354.
25. Voon V, Fernagut PO, Wickens J, et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol 2009; 8: 1140-1149.
26. Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG. Levodopa-induced dyskinesias. Mov Disord 2007; 22: 1379-1389; quiz 1523.
27. Taira T, Kobayashi T, Hori T. Disappearance of self-mutilating behavior in a patient with lesch-nyhan syndrome after bilateral chronic stimulation of the globus pallidus internus. Case report. J Neurosurg 2003; 98: 414-416.
28. Grattan-Smith PJ, Wevers RA, Steenbergen-Spanjers GC, Fung VS, Earl J, Wilcken B. Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy. Mov Disord 2002; 17: 354-359.
29. Cif L, Biolsi B, Gavarini S, et al. Antero-ventral internal pallidum stimulation improves behavioral disorders in Lesch-Nyhan disease. Mov Disord 2007; 22: 2126-2129.
30. Pralong E, Pollo C, Coubes P, et al. Electrophysiological characteristics of limbic and motor globus pallidus internus (GPI) neurons in two cases of Lesch-Nyhan syndrome. Neurophysiol Clin 2005; 35: 168-173.